The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.
Immunology • Vol. 160, Issue 1 • 2020
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18.
The Journal of pharmacology and experimental therapeutics • Vol. 321, Issue 2 • 2007
Modification of graft-versus-host disease with con A and preimmunization.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) • Vol. 150, Issue 3 • 1975
